ellaOne (ulipristal acetate)
- Region
- 🇪🇺 EU
- Active substance
- ulipristal acetate
- Company
- Laboratoire HRA Pharma
- Status
- Authorised
- Therapeutic area
- Contraception, Postcoital
- EU approval
- Fri 15 May 2009
- Application
- EMEA/H/C/001027
- ATC
- G03AD02
- Official record
- www.ema.europa.eu
Indication
Emergency contraception within 120 hours (five days) of unprotected sexual intercourse or contraceptive failure.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Ulipristal Acetate Gedeon Richter Withdrawn · Gedeon Richter Plc.
Follow ellaOne
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.